TECHDOW PHARMA ENGLAND LIMITED
Get an alert when TECHDOW PHARMA ENGLAND LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-12-19 (in 7mo)
Last made up 2025-12-05
Watchouts
None on the register
Cash
£9M
-31.7% vs 2023
Net assets
-£2M
+27.1% highest in 6 filed years
Employees
11
+10% highest in 6 filed years
Profit before tax
£975K
-79.1% first positive since 2021
Net assets
10-year trend · vs Consumer Discretionary median
Accounts
10-year trend · latest reflected 2024-12-31
| Metric | Trend | 2019-12-31 | 2020-01-01 | 2020-12-31 | 2021-01-01 | 2021-12-31 | 2022-01-01 | 2022-12-31 | 2023-01-01 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | £21,112,497 | — | £23,020,829 | — | £31,674,721 | — | £42,844,591 | — | £49,912,155 | £39,675,728 | |
| Operating profit | -£2,719,826 | — | -£1,167,354 | — | -£6,601,447 | — | £5,533,931 | — | £4,716,550 | £999,937 | |
| Profit before tax | -£2,732,917 | — | -£1,170,969 | — | -£6,626,980 | — | £5,485,081 | — | £4,658,091 | £974,795 | |
| Net profit | -£2,732,917 | — | -£1,170,969 | — | -£6,626,980 | — | £5,439,048 | — | £5,605,796 | £730,293 | |
| Cash | £2,893,097 | £2,893,097 | £5,639,057 | — | £9,230,843 | £9,230,843 | £10,272,487 | £10,272,487 | £13,885,969 | £9,478,356 | |
| Total assets less current liabilities | -£5,937,747 | — | -£7,108,716 | — | -£13,735,696 | — | -£8,296,648 | — | -£2,690,852 | -£1,960,559 | |
| Net assets | -£5,937,747 | — | -£7,108,716 | — | -£13,735,696 | — | -£8,296,648 | — | -£2,690,852 | -£1,960,559 | |
| Equity | -£5,937,747 | -£5,937,747 | -£7,108,716 | -£7,108,716 | -£13,735,696 | -£13,735,696 | -£8,296,648 | -£8,296,648 | -£2,690,852 | -£1,960,559 | |
| Average employees | 9 | — | 8 | — | 8 | — | 8 | — | 10 | 11 | |
| Wages | £725,116 | — | £850,728 | — | £542,206 | — | £925,903 | — | £904,059 | £1,218,183 | |
| Directors' remuneration | — | — | — | — | — | — | — | — | £0 | £0 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-20.5%
£49,912,155 £39,675,728
-
Cash
-31.7%
£13,885,969 £9,478,356
-
Net assets
+27.1%
-£2,690,852 -£1,960,559
highest in 6 filed years
-
Employees
+10%
10 11
highest in 6 filed years
-
Operating profit
-78.8%
£4,716,550 £999,937
first positive since 2021
-
Profit before tax
-79.1%
£4,658,091 £974,795
first positive since 2021
-
Wages
+34.7%
£904,059 £1,218,183
highest in 6 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-12-31 | 2020-01-01 | 2020-12-31 | 2021-01-01 | 2021-12-31 | 2022-01-01 | 2022-12-31 | 2023-01-01 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -12.9% | — | -5.1% | — | -20.8% | — | 12.9% | — | 9.4% | 2.5% | |
| Net margin | -12.9% | — | -5.1% | — | -20.9% | — | 12.7% | — | 11.2% | 1.8% | |
| Return on capital employed | 45.8% | — | 16.4% | — | 48.1% | — | -66.7% | — | -175.3% | -51.0% | |
| Current ratio | — | — | — | — | — | — | — | — | 0.93x | 0.96x | |
| Interest cover | -207.76x | — | -322.92x | — | -258.55x | — | 113.28x | — | 80.68x | 38.96x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements are prepared on a going concern basis. The Company remains assured of the financial support provided by Shenzhen Hepalink Pharmaceutical Group Co., Ltd., the ultimate controlling party. The directors have received confirmation that Shenzhen Hepalink Pharmaceutical Group Co., Ltd. will continue to support the Company and provide it with adequate funds when necessary to enable it to meet its debts as they fall due in the foreseeable future. On this basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHEN, Juan | Director | 2024-05-01 | Oct 1975 | Chinese |
| GEORGE, Paula | Director | 2023-03-01 | Aug 1964 | British |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| PINSENT MASONS SECRETARIAL LIMITED | Corporate Secretary | 2016-12-06 | 2017-08-31 |
| HIGGINS, Stephen John | Director | 2017-08-01 | 2020-04-30 |
| LI, Jianke | Director | 2017-12-01 | 2019-08-27 |
| LING, Xing | Director | 2019-08-27 | 2020-06-29 |
| SHI, Wen | Director | 2020-06-29 | 2023-08-23 |
| ZIEBA, Rafal Piotr | Director | 2016-12-06 | 2017-08-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Techdow Pharma Netherlands Bv | Corporate entity | Significant influence | 2020-04-01 | Active |
| Rafal Piotr Zieba | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-12-06 | Ceased 2020-03-30 |
Filing timeline
Last 20 of 44 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-12-17 | AA | accounts | Accounts with accounts type full | |
| 2025-01-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-25 | AA | accounts | Accounts with accounts type full | |
| 2024-05-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-12-07 | AA | accounts | Accounts with accounts type full | |
| 2023-12-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-23 | TM01 | officers | Termination director company with name termination date | |
| 2023-03-09 | AP01 | officers | Appoint person director company with name date | |
| 2022-12-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-30 | AA | accounts | Accounts with accounts type full | |
| 2021-12-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-07 | AA | accounts | Accounts with accounts type full | |
| 2021-04-27 | AA | accounts | Accounts with accounts type full | |
| 2021-04-23 | DISS40 | gazette | Gazette filings brought up to date | |
| 2021-04-20 | GAZ1 | gazette | Gazette notice compulsory | |
| 2020-12-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-07-08 | AP01 | officers | Appoint person director company with name date | |
| 2020-07-07 | TM01 | officers | Termination director company with name termination date | |
| 2020-05-15 | PSC02 | persons-with-significant-control | Notification of a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.